Results 1 to 10 of about 17,628 (245)

The multiverse of CD46 and oncologic interactions [PDF]

open access: yesThe Journal of Clinical Investigation
Initially identified as a regulator of complement activation on host cells, the known roles of CD46 (membrane cofactor protein [MCP]) have expanded. We now know that this ancient molecule is expressed on almost all nucleated cells as a family of four ...
M. Kathryn Liszewski, John P. Atkinson
doaj   +4 more sources

CD46 Null Packaging Cell Line Improves Measles Lentiviral Vector Production and Gene Delivery to Hematopoietic Stem and Progenitor Cells [PDF]

open access: goldMolecular Therapy: Methods & Clinical Development, 2019
Lentiviral vectors (LVs) pseudotyped with the measles virus hemagglutinin (H) and fusion (F) glycoproteins have been reported to more efficiently transduce hematopoietic stem and progenitor cells (HSPCs) compared with vesicular stomatitis virus ...
Stosh Ozog   +7 more
doaj   +2 more sources

Identification of a new CD46 gene mutation site in a family with atypical hemolytic uremic syndrome [PDF]

open access: yesBMC Nephrology
Background Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy resulting from the dysregulation of the alternative complement pathway.
Benjin Hu   +6 more
doaj   +2 more sources

Primary Cells from a CD46-Edited Bovine Heifer Have Reduced BVDV Susceptibility Despite Viral Adaptation to Heparan Sulfate [PDF]

open access: yesViruses
A precision genome edit in the bovine CD46 gene (A82LPTFS87) dramatically reduced bovine viral diarrhea virus (BVDV) susceptibility in a cloned heifer. However, pathogen evolution threatens the long-term efficacy of such interventions.
Alexandria C. Krueger   +4 more
doaj   +2 more sources

Complement gene expression profiles are altered in the AD frontal cortex [PDF]

open access: yesAlzheimers Dement
Abstract Background Complement contributes significantly to pathophysiology in many neurodegenerative diseases (NDDs) including Alzheimer's Disease (AD); yet, the source of complement in the brain is poorly understood. Even multiple small changes to individual complement components can compound into significant dysregulation of the whole system ...
Bright M, Nguyen V, Morgan B, Zelek W.
europepmc   +2 more sources

CD46 is a cellular receptor for species D human adenovirus [PDF]

open access: yesmBio
Human adenovirus species D (HAdV-D) contains two-thirds of all known HAdV types (116 in total) and is important as a vector in clinical applications. However, the broad tropism exhibited by several HAdV-D types poses challenges for their use as targeted ...
Katarina Danskog   +6 more
doaj   +2 more sources

CD46 Is a Protein Receptor for Human Adenovirus Type 64 [PDF]

open access: yesViruses
Certain species D human adenoviruses (HAdV-D19, -D37, and -D64) are causative agents of epidemic keratoconjunctivitis. HAdV-D37 has previously been shown to bind CD46 (membrane cofactor protein) and sialic acid as adhesion receptors.
Eugene Y. Wu   +8 more
doaj   +2 more sources

CD46 Gene Editing Confers Ex Vivo BVDV Resistance in Fibroblasts from Cloned Angus Calves [PDF]

open access: yesViruses
A previous study demonstrated that a 19-nucleotide edit, encoding a six amino acid substitution in the bovine CD46 gene, dramatically reduced bovine viral diarrhea virus (BVDV) susceptibility in a cloned Gir (Bos indicus) heifer.
Aspen M. Workman   +2 more
doaj   +2 more sources

Association Between Promoter Polymorphisms in CD46 and CD59 in Kidney Donors and Transplant Outcome

open access: goldFrontiers in Immunology, 2018
Complement regulating proteins, including CD46, CD55, and CD59, protect cells against self-damage. Because of their expression on the donor endothelium, they are hypothesized to be involved in accommodation.
Laura A. Michielsen   +4 more
doaj   +2 more sources

CD46 TREM1 regulates the autophagy marker LC3B ATG5 in oral squamous cell carcinoma [PDF]

open access: yesFrontiers in Oncology
ObjectiveThis study aims to explore the regulatory effect of abnormal expression of CD46 and TREM1 on LC3B and ATG5 and to provide new targets for the molecular mechanism and treatment of OSCC.
Xiaodan Liu   +8 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy